Duarte-Garcia, A., Eder, L., Goel, N., Wit, M. D., Gladman, D. D., Fitzgerald, O., … Ogdie, A. (2019). SAT0395 RESPONSIVENESS AND CLINICAL TRIAL DISCRIMINATION OF SWOLLEN AND TENDER JOINT COUNTS FOR THE MEASUREMENT OF MSK DISEASE ACTIVITY IN PSORIATIC ARTHRITIS. In Annals of the Rheumatic Diseases (Vol. 78, pp. 1284–1285). Elsevier BV. https://doi.org/10.1136/annrheumdis-2019-eular.1659

Duarte-Garcia, Ali, Lihi Eder, Niti Goel, Maarten de Wit, Dafna D. Gladman, Oliver Fitzgerald, Philip J. Mease, et al. “SAT0395 RESPONSIVENESS AND CLINICAL TRIAL DISCRIMINATION OF SWOLLEN AND TENDER JOINT COUNTS FOR THE MEASUREMENT OF MSK DISEASE ACTIVITY IN PSORIATIC ARTHRITIS.” In Annals of the Rheumatic Diseases, 78:1284–85. Elsevier BV, 2019. https://doi.org/10.1136/annrheumdis-2019-eular.1659.

Duarte-Garcia A, Eder L, Goel N, Wit MD, Gladman DD, Fitzgerald O, et al. SAT0395 RESPONSIVENESS AND CLINICAL TRIAL DISCRIMINATION OF SWOLLEN AND TENDER JOINT COUNTS FOR THE MEASUREMENT OF MSK DISEASE ACTIVITY IN PSORIATIC ARTHRITIS. In: Annals of the Rheumatic Diseases. Elsevier BV; 2019. p. 1284–5.

Duarte-Garcia, Ali, et al. “SAT0395 RESPONSIVENESS AND CLINICAL TRIAL DISCRIMINATION OF SWOLLEN AND TENDER JOINT COUNTS FOR THE MEASUREMENT OF MSK DISEASE ACTIVITY IN PSORIATIC ARTHRITIS.” Annals of the Rheumatic Diseases, vol. 78, Elsevier BV, 2019, pp. 1284–85. Crossref, doi:10.1136/annrheumdis-2019-eular.1659.

Duarte-Garcia A, Eder L, Goel N, Wit MD, Gladman DD, Fitzgerald O, Mease PJ, Leung YY, Orbai A-M, Shea B, Strand V, Helliwell P, Stephens-Shields A, Tillett W, Coates LC, Ogdie A. SAT0395 RESPONSIVENESS AND CLINICAL TRIAL DISCRIMINATION OF SWOLLEN AND TENDER JOINT COUNTS FOR THE MEASUREMENT OF MSK DISEASE ACTIVITY IN PSORIATIC ARTHRITIS. Annals of the Rheumatic Diseases. Elsevier BV; 2019. p. 1284–1285.